SCHEMBL971952

SCHEMBL971952

CCOC(=O)c1s[c]nc1C

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
HPGD P15428 3/20 0.44
CYP1A2 P05177 1/20 0.44
NPC1 O15118 3/20 0.42
MAPT P10636 2/20 0.42
RAB9A P51151 2/20 0.42
HSD17B10 Q99714 3/20 0.42
GAA P10253 2/20 0.41
KMT2A Q03164 1/20 0.41
MC4R P32245 1/20 0.41
CDC7 O00311 2/20 0.41
DBF4 Q9UBU7 2/20 0.41
TRPM8 Q7Z2W7 1/20 0.41
PDE4D Q08499 1/20 0.41
TSHR P16473 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9842107 0.84 ALDH1A1 (0.50) ALDH1A1HPGDCYP1A2NPC1MAPT
SCHEMBL2442977 0.82 LMNA (0.49) ALDH1A1HPGDCYP1A2NPC1MAPT
SCHEMBL2440590 0.82 ALDH1A1 (0.36) ALDH1A1HPGDCYP1A2NPC1MAPT
SCHEMBL2447674 0.81 MAPT (0.41) ALDH1A1HPGDNPC1MAPTRAB9A
SCHEMBL330112 0.80 ALDH1A1 (0.54) ALDH1A1HPGDCYP1A2NPC1MAPT
SCHEMBL330232 0.78 KDM4E (0.43) ALDH1A1HPGDCYP1A2NPC1MAPT
SCHEMBL330020 0.76 ALDH1A1 (0.39) ALDH1A1HPGDCYP1A2NPC1MAPT
SCHEMBL330385 0.76 ALDH1A1 (0.59) ALDH1A1HPGDCYP1A2NPC1MAPT
SCHEMBL2440626 0.76
SCHEMBL7236189 0.74 ALDH1A1 (0.44) ALDH1A1HPGDCYP1A2NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220153713-A1 HYDRAZONE AMIDE DERIVATIVE AND APPLICATION THEREOF IN PREPARATION OF MEDICAMENTS FOR PREVENTING AND TREATING ALOPECIA SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT CO., LTD. (CN) 2022-05-19 US claimed
US-20220153688-A1 HYDRAZONE AMIDE DERIVATIVES AND USE THEREOF IN PREPARATION OF ANTI-OSTEOPOROSIS DRUGS SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT CO., LTD. (CN) 2022-05-19 US claimed
CN-104206385-A Use of amine compound as bactericide SINOCHEM CORP 2014-12-17 CN claimed
CN-102942565-A 3,4-dichloro isothiazole derivatives, their preparation method and application JIANGXI TIANREN ECOLOGY CO LTD 2013-02-27 CN claimed
US-20100311748-A1 HETEROCYCLIC AMIDES USEFUL FOR THE TREATMENT OF CANCER AND PSORIASIS ASTRAZENECA AB (SE) 2010-12-09 US claimed
CN-101835752-A Heterocyclic amides useful for the treatment of cancer and psoriasis ASTRAZENECA AB 2010-09-15 CN claimed
EP-2188255-A1 HETEROCYCLIC AMIDES USEFUL FOR THE TREATMENT OF CANCER AND PSORIASIS AstraZeneca AB (SE) 2010-05-26 EP claimed
WO-2009027746-A1 HETEROCYCLIC AMIDES USEFUL FOR THE TREATMENT OF CANCER AND PSORIASIS ASTRAZENECA AB (SE) 2009-03-05 WO claimed
US-5371074-A Use of saccharin derivatives as proteolytic enzyme inhibitors STERLING WINTHROP INC. (US) 1994-12-06 US claimed
EP-0542372-A1 2-Substituted saccharin derivative proteolytic enzyme inhibitors STERLING WINTHROP INC. (US) 1993-05-19 EP claimed
EP-0035886-B1 SOLID-STATE IMAGING DEVICE HAVING A COLOR FILTER ARRAY AND METHODS OF PREPARING SAME EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1985-11-27 EP claimed
EP-0061094-B1 ELECTROPHOTOGRAPHIC RECORDING MATERIAL BASF Aktiengesellschaft (DE) 1985-10-02 EP claimed
US-4481272-A ISOINDOLE DYES BASF AKTIENGESELLSCHAFT (DE) 1984-11-06 US claimed
EP-0061094-A1 Electrophotographic recording material BASF Aktiengesellschaft (DE) 1982-09-29 EP claimed
US-4102688-A CONTAINING PYRAZOLO(3,4-B)PYRIDINE/3,6-DIONE MOIETY FUJI PHOTO FILM CO., LTD. (JP) 1978-07-25 US claimed
US-20220153713-A1 HYDRAZONE AMIDE DERIVATIVE AND APPLICATION THEREOF IN PREPARATION OF MEDICAMENTS FOR PREVENTING AND TREATING ALOPECIA SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT CO., LTD. (CN) 2022-05-19 US disclosed
US-20220153688-A1 HYDRAZONE AMIDE DERIVATIVES AND USE THEREOF IN PREPARATION OF ANTI-OSTEOPOROSIS DRUGS SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT CO., LTD. (CN) 2022-05-19 US disclosed
US-4102688-A CONTAINING PYRAZOLO(3,4-B)PYRIDINE/3,6-DIONE MOIETY FUJI PHOTO FILM CO., LTD. (JP) 1978-07-25 US disclosed
US-3979369-A DIENE POLYMER MONSANTO COMPANY (US) 1976-09-07 US disclosed
US-3974170-A SULFONATES, SULFINATES MONSANTO COMPANY (US) 1976-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153688-A1 HYDRAZONE AMIDE DERIVATIVES AND USE THEREOF IN PREPARATION OF ANTI-OSTEOPOROSIS DRUGS SOST, HDAC5, PTH1R ALDH1A1 644/4885HPGD 34/4885CYP1A2 265/4885
US-20100311748-A1 HETEROCYCLIC AMIDES USEFUL FOR THE TREATMENT OF CANCER AND PSORIASIS SHH, GLI1, HRH4 ALDH1A1 1711/4885HPGD 87/4885CYP1A2 1878/4885
US-20220153713-A1 HYDRAZONE AMIDE DERIVATIVE AND APPLICATION THEREOF IN PREPARATION OF MEDICAMENTS FOR PREVENTING AND TREATING ALOPECIA FH, HDGF, HRH4 ALDH1A1 652/4885HPGD 33/4885CYP1A2 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.